alendronate vs ibandronate
Side-by-side comparison of alendronate and ibandronate Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Fosamax
Boniva
Binosto is a medicine that helps make your bones stronger. It is used to treat osteoporosis in women after menopause and in men.
Ibandronate (Boniva) is a medicine that helps treat and prevent bone loss in women after menopause. It makes bones stronger and less likely to break.
Binosto treats osteoporosis, a condition that weakens bones and makes them more likely to break. It helps to increase bone mass in both postmenopausal women and men who have osteoporosis. Using this medicine can lower your chance of having fractures, including hip and spine fractures. Talk to your doctor about how long you should take this medicine.
Ibandronate is used to treat and prevent osteoporosis in women after menopause. Osteoporosis is a condition that makes bones weak and more likely to break. This medicine helps to increase bone strength and reduce the chance of fractures, especially in the spine.
Binosto belongs to a class of drugs called bisphosphonates. It works by slowing down the breakdown of bone in your body. This helps to increase bone density and reduce the risk of fractures.
Ibandronate belongs to a class of drugs called bisphosphonates. It works by slowing down the breakdown of bone. This helps to increase bone density and reduce the risk of fractures.
- • Abdominal pain
- • Acid reflux
- • Constipation
- • Diarrhea
- • Upset stomach
- • Back pain
- • Upset stomach
- • Pain in arms or legs
- • Diarrhea
- • Headache
- Pain 13,524
- Tiredness 12,776
- The medicine is not working 12,331
- Fracture of the thigh bone 11,334
- Joint pain 11,000
- Joint pain 243
- Diarrhea 230
- Feeling sick to your stomach 219
- Broken thigh bone 216
- Headache 198
Binosto can cause problems with your esophagus. Follow the directions for taking it carefully. If you have new or worsening heartburn, pain when swallowing, or chest pain, stop taking Binosto and call your doctor. This medicine may also cause severe bone, joint, or muscle pain. If you develop these symptoms, stop taking Binosto and contact your doctor.
This medicine can cause problems with your esophagus. To help prevent this, follow the directions carefully and stay upright for at least 60 minutes after taking it. Rarely, serious bone, joint, or muscle pain can occur. Tell your doctor if you have new pain in your thigh or groin. Osteonecrosis of the jaw (bone damage in the jaw) has been reported.
Stop taking Binosto if you become pregnant. Bisphosphonates can stay in your bones for many years and could potentially harm the baby's skeleton.
Ibandronate is not for use in women who can get pregnant. It is not known if this medicine will harm an unborn baby. Talk to your doctor if you are breastfeeding.
Also Compare — Nearby Drugs
Compare alendronate with
Compare ibandronate with
How to Read This alendronate vs ibandronate Comparison
alendronate is classified in the Bisphosphonate drug class, while ibandronate sits within the Bisphosphonate class. Because both drugs share the same classification, they are often considered interchangeable in theory — but clinical outcomes rarely track that cleanly. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, alendronate has 60,965 submissions while ibandronate has 1,106. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between alendronate and ibandronate — always consult your physician or pharmacist first.
Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.